EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease (KAT301)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Kuopio University Hospital
Sponsor:
Collaborator:
University of Eastern Finland
Information provided by (Responsible Party):
Juha Hartikainen, Kuopio University Hospital
ClinicalTrials.gov Identifier:
NCT01002430
First received: October 23, 2009
Last updated: March 31, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)